BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burke W, Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, Holm IA, Jarvik GP, Khoury MJ, Knoppers BM, Press NA, Ross LF, Rothstein MA, Saal H, Uhlmann WR, Wilfond B, Wolf SM, Zimmern R. Recommendations for returning genomic incidental findings? We need to talk! Genet Med 2013;15:854-9. [PMID: 23907645 DOI: 10.1038/gim.2013.113] [Cited by in Crossref: 209] [Cited by in F6Publishing: 194] [Article Influence: 23.2] [Reference Citation Analysis]
Number Citing Articles
1 Bertolotti M. Opportunities, Risks, and Limitations of Genetic Testing: Looking to the Future From Patients' Point of View. Mayo Clin Proc 2015;90:1311-3. [PMID: 26434956 DOI: 10.1016/j.mayocp.2015.08.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Deverka PA, Dreyfus JC. Clinical integration of next generation sequencing: coverage and reimbursement challenges. J Law Med Ethics 2014;42 Suppl 1:22-41. [PMID: 25298289 DOI: 10.1111/jlme.12160] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
3 Wolf SM, Branum R, Koenig BA, Petersen GM, Berry SA, Beskow LM, Daly MB, Fernandez CV, Green RC, LeRoy BS, Lindor NM, O'Rourke PP, Breitkopf CR, Rothstein MA, Van Ness B, Wilfond BS. Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations. J Law Med Ethics 2015;43:440-63. [PMID: 26479555 DOI: 10.1111/jlme.12288] [Cited by in Crossref: 18] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
4 Kaufman D, Curnutte M, McGuire AL. Clinical integration of next generation sequencing: a policy analysis. J Law Med Ethics 2014;42 Suppl 1:5-8. [PMID: 25298287 DOI: 10.1111/jlme.12158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Henderson GE, Wolf SM, Kuczynski KJ, Joffe S, Sharp RR, Parsons DW, Knoppers BM, Yu JH, Appelbaum PS. The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations. J Law Med Ethics 2014;42:344-55. [PMID: 25264092 DOI: 10.1111/jlme.12151] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
6 Nishimura AA, Tarczy-Hornoch P, Shirts BH. Pragmatic and Ethical Challenges of Incorporating the Genome into the Electronic Medical Record. Curr Genet Med Rep 2014;2:201-11. [PMID: 26146597 DOI: 10.1007/s40142-014-0051-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gliwa C, Yurkiewicz IR, Lehmann LS, Hull SC, Jones N, Berkman BE. Institutional review board perspectives on obligations to disclose genetic incidental findings to research participants. Genet Med 2016;18:705-11. [PMID: 26583685 DOI: 10.1038/gim.2015.149] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
8 Rahimzadeh V, Knoppers BM, Bartlett G. Ethical, Legal, and Social Issues (ELSI) of Responsible Data Sharing Involving Children in Genomics: A Systematic Literature Review of Reasons. AJOB Empir Bioeth 2020;11:233-45. [PMID: 32975491 DOI: 10.1080/23294515.2020.1818875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 Nishimura AA, Shirts BH, Dorschner MO, Amendola LM, Smith JW, Jarvik GP, Tarczy-Hornoch P. Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing. Genet Med 2015;17:939-42. [PMID: 25741865 DOI: 10.1038/gim.2015.5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
10 Aas M, Blokland GA, Chawner SJ, Choi SW, Estrada J, Forsingdal A, Friedrich M, Ganesham S, Hall L, Haslinger D, Huckins L, Loken E, Malan-Müller S, Martin J, Misiewicz Z, Pagliaroli L, Pardiñas AF, Pisanu C, Quadri G, Santoro ML, Shaw AD, Ranlund S, Song J, Tesli M, Tropeano M, van der Voet M, Wolfe K, Cormack FK, DeLisi L. Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014. Psychiatr Genet 2016;26:1-47. [PMID: 26565519 DOI: 10.1097/YPG.0000000000000112] [Reference Citation Analysis]
11 Duong B, Savarirayan R, Winship I. Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned. Familial Cancer 2016;15:25-9. [DOI: 10.1007/s10689-015-9829-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
12 Kaphingst KA, Ivanovich J, Lyons S, Biesecker B, Dresser R, Elrick A, Matsen C, Goodman M. Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors. Transl Behav Med 2018;8:71-9. [PMID: 29385583 DOI: 10.1093/tbm/ibx042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
13 Pervola J, Myers MF, McGowan ML, Prows CA. Giving adolescents a voice: the types of genetic information adolescents choose to learn and why. Genet Med 2019;21:965-71. [PMID: 30369597 DOI: 10.1038/s41436-018-0320-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
14 Rost C, Dent KM, Botkin J, Rothwell E. Experiences and lessons learned by genetic counselors in returning secondary genetic findings to patients. J Genet Couns 2020;29:1234-44. [PMID: 32453499 DOI: 10.1002/jgc4.1292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Ackerman SL, Koenig BA. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories. AJOB Empirical Bioethics 2017;9:48-57. [DOI: 10.1080/23294515.2017.1405095] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
16 Gehlert S, Mozersky J. Seeing Beyond the Margins: Challenges to Informed Inclusion of Vulnerable Populations in Research. J Law Med Ethics 2018;46:30-43. [PMID: 30093794 DOI: 10.1177/1073110518766006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
17 Appelbaum PS, Parens E, Waldman CR, Klitzman R, Fyer A, Martinez J, Price WN 2nd, Chung WK. Models of consent to return of incidental findings in genomic research. Hastings Cent Rep 2014;44:22-32. [PMID: 24919982 DOI: 10.1002/hast.328] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
18 Albrechtsen RD, Goodman MS, Bather JR, Kaphingst KA. Impact of numeracy preferences on information needs for genome sequencing results. Patient Educ Couns 2021;104:467-72. [PMID: 33036816 DOI: 10.1016/j.pec.2020.09.032] [Reference Citation Analysis]
19 Roche MI, Berg JS. Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice. Curr Genet Med Rep 2015;3:166-76. [PMID: 26566463 DOI: 10.1007/s40142-015-0075-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
20 Henderson GE, Edwards TP, Cadigan RJ, Davis AM, Zimmer C, Conlon I, Weiner BJ. Stewardship practices of U.S. biobanks. Sci Transl Med 2013;5:215cm7. [PMID: 24337477 DOI: 10.1126/scitranslmed.3007362] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
21 Seaby EG, Pengelly RJ, Ennis S. Exome sequencing explained: a practical guide to its clinical application. Brief Funct Genomics 2016;15:374-84. [PMID: 26654982 DOI: 10.1093/bfgp/elv054] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
22 Kuhlen M, Borkhardt A. Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing. Eur J Pediatr 2015;174:987-97. [PMID: 25982339 DOI: 10.1007/s00431-015-2565-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
23 Bennette CS, Gallego CJ, Burke W, Jarvik GP, Veenstra DL. The cost-effectiveness of returning incidental findings from next-generation genomic sequencing. Genet Med 2015;17:587-95. [PMID: 25394171 DOI: 10.1038/gim.2014.156] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
24 Wolyniec K, Sharp J, Lazarakis S, Mileshkin L, Schofield P. Understanding and information needs of cancer patients regarding treatment‐focused genomic testing: A systematic review. Psycho‐Oncology 2020;29:632-8. [DOI: 10.1002/pon.5351] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
25 Bardakjian T, Gonzalez-alegre P. Towards precision medicine. Neurogenetics, Part I. Elsevier; 2018. pp. 93-102. [DOI: 10.1016/b978-0-444-63233-3.00008-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
26 Bayefsky MJ, Berkman BE. Implementing Expanded Prenatal Genetic Testing: Should Parents Have Access to Any and All Fetal Genetic Information? Am J Bioeth 2021;:1-26. [PMID: 33459580 DOI: 10.1080/15265161.2020.1867933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kesserwan C, Friedman Ross L, Bradbury AR, Nichols KE. The Advantages and Challenges of Testing Children for Heritable Predisposition to Cancer. Am Soc Clin Oncol Educ Book 2016;35:251-69. [PMID: 27249705 DOI: 10.1200/EDBK_160621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
28 Sénécal K, Thys K, Vears DF, Van Assche K, Knoppers BM, Borry P. Legal approaches regarding health-care decisions involving minors: implications for next-generation sequencing. Eur J Hum Genet 2016;24:1559-64. [PMID: 27302841 DOI: 10.1038/ejhg.2016.61] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Ross LF, Clayton EW. Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq. Pediatrics 2019;144:e20191031. [PMID: 31719124 DOI: 10.1542/peds.2019-1031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
30 Hylind R, Smith M, Rasmussen-Torvik L, Aufox S. Great expectations: patient perspectives and anticipated utility of non-diagnostic genomic-sequencing results. J Community Genet 2018;9:19-26. [PMID: 28656483 DOI: 10.1007/s12687-017-0314-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
31 Trinidad SB, Fullerton SM, Burke W. Looking for Trouble and Finding It. Am J Bioeth 2015;15:15-7. [PMID: 26147255 DOI: 10.1080/15265161.2015.1039731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Rini C, Roche MI, Lin FC, Foreman AKM, Khan CM, Griesemer I, Waltz M, Lee K, O'Daniel JM, Evans JP, Berg JS, Henderson GE. Burden or benefit? Effects of providing education about and the option to request additional genomic findings from diagnostic exome sequencing: A randomized controlled trial. Patient Educ Couns 2021:S0738-3991(21)00291-3. [PMID: 33966955 DOI: 10.1016/j.pec.2021.04.026] [Reference Citation Analysis]
33 Hegde M, Bale S, Bayrak-Toydemir P, Gibson J, Jeng LJ, Joseph L, Laser J, Lubin IM, Miller CE, Ross LF, Rothberg PG, Tanner AK, Vitazka P, Mao R. Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology. J Mol Diagn 2015;17:107-17. [PMID: 25684271 DOI: 10.1016/j.jmoldx.2014.10.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.9] [Reference Citation Analysis]
34 Burke W, Appelbaum P, Dame L, Marshall P, Press N, Pyeritz R, Sharp R, Juengst E. The translational potential of research on the ethical, legal, and social implications of genomics. Genet Med 2015;17:12-20. [PMID: 24946153 DOI: 10.1038/gim.2014.74] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
35 Jarvik GP, Amendola LM, Berg JS, Brothers K, Clayton EW, Chung W, Evans BJ, Evans JP, Fullerton SM, Gallego CJ, Garrison NA, Gray SW, Holm IA, Kullo IJ, Lehmann LS, McCarty C, Prows CA, Rehm HL, Sharp RR, Salama J, Sanderson S, Van Driest SL, Williams MS, Wolf SM, Wolf WA, Burke W; eMERGE Act-ROR Committee and CERC Committee., CSER Act-ROR Working Group. Return of genomic results to research participants: the floor, the ceiling, and the choices in between. Am J Hum Genet 2014;94:818-26. [PMID: 24814192 DOI: 10.1016/j.ajhg.2014.04.009] [Cited by in Crossref: 244] [Cited by in F6Publishing: 220] [Article Influence: 30.5] [Reference Citation Analysis]
36 Hippman C, Nislow C. Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges. J Pers Med 2019;9:E40. [PMID: 31394823 DOI: 10.3390/jpm9030040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
37 Botkin JR. Ethical issues in pediatric genetic testing and screening. Curr Opin Pediatr 2016;28:700-4. [PMID: 27606958 DOI: 10.1097/MOP.0000000000000418] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
38 Hehir-Kwa JY, Claustres M, Hastings RJ, van Ravenswaaij-Arts C, Christenhusz G, Genuardi M, Melegh B, Cambon-Thomsen A, Patsalis P, Vermeesch J, Cornel MC, Searle B, Palotie A, Capoluongo E, Peterlin B, Estivill X, Robinson PN. Towards a European consensus for reporting incidental findings during clinical NGS testing. Eur J Hum Genet 2015;23:1601-6. [PMID: 26036857 DOI: 10.1038/ejhg.2015.111] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 8.9] [Reference Citation Analysis]
39 Vears DF, Sénécal K, Borry P. Reporting practices for unsolicited and secondary findings from next-generation sequencing technologies: Perspectives of laboratory personnel. Hum Mutat 2017;38:905-11. [PMID: 28512758 DOI: 10.1002/humu.23259] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
40 Lázaro-Muñoz G, Farrell MS, Crowley JJ, Filmyer DM, Shaughnessy RA, Josiassen RC, Sullivan PF. Improved ethical guidance for the return of results from psychiatric genomics research. Mol Psychiatry 2018;23:15-23. [PMID: 29158581 DOI: 10.1038/mp.2017.228] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
41 Kaphingst KA, Ivanovich J, Biesecker BB, Dresser R, Seo J, Dressler LG, Goodfellow PJ, Goodman MS. Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age. Clin Genet 2016;89:378-84. [PMID: 25871653 DOI: 10.1111/cge.12597] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
42 Green RC, Goddard KAB, Jarvik GP, Amendola LM, Appelbaum PS, Berg JS, Bernhardt BA, Biesecker LG, Biswas S, Blout CL, Bowling KM, Brothers KB, Burke W, Caga-Anan CF, Chinnaiyan AM, Chung WK, Clayton EW, Cooper GM, East K, Evans JP, Fullerton SM, Garraway LA, Garrett JR, Gray SW, Henderson GE, Hindorff LA, Holm IA, Lewis MH, Hutter CM, Janne PA, Joffe S, Kaufman D, Knoppers BM, Koenig BA, Krantz ID, Manolio TA, McCullough L, McEwen J, McGuire A, Muzny D, Myers RM, Nickerson DA, Ou J, Parsons DW, Petersen GM, Plon SE, Rehm HL, Roberts JS, Robinson D, Salama JS, Scollon S, Sharp RR, Shirts B, Spinner NB, Tabor HK, Tarczy-Hornoch P, Veenstra DL, Wagle N, Weck K, Wilfond BS, Wilhelmsen K, Wolf SM, Wynn J, Yu JH; CSER Consortium. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am J Hum Genet 2016;98:1051-66. [PMID: 27181682 DOI: 10.1016/j.ajhg.2016.04.011] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 16.0] [Reference Citation Analysis]
43 Rigter T, van Aart CJ, Elting MW, Waisfisz Q, Cornel MC, Henneman L. Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients. Clin Genet 2014;85:417-22. [PMID: 24117109 DOI: 10.1111/cge.12299] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
44 Bush L. In the Best Interest of the Child: Psychological and Ethical Reflections on Traditions, Contexts, and Perspectives in Pediatric Clinical Genomics. The American Journal of Bioethics 2014;14:16-8. [DOI: 10.1080/15265161.2013.879962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
45 Zierhut HA, Campbell CA, Mitchell AG, Lemke AA, Mills R, Bishop JR. Collaborative Counseling Considerations for Pharmacogenomic Tests. Pharmacotherapy 2017;37:990-9. [DOI: 10.1002/phar.1980] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
46 Katsanis SH, Minear MA, Vorderstrasse A, Yang N, Reeves JW, Rakhra-Burris T, Cook-Deegan R, Ginsburg GS, Simmons LA. Perspectives on genetic and genomic technologies in an academic medical center: the duke experience. J Pers Med 2015;5:67-82. [PMID: 25854543 DOI: 10.3390/jpm5020067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
47 Yu MHC, Mak CCY, Fung JLF, Lee M, Tsang MHY, Chau JFT, Chung PH, Yang W, Chan GCF, Lee SL, Lau YL, Tam PKH, Tang CSM, Yeung KS, Chung BHY. Actionable secondary findings in 1116 Hong Kong Chinese based on exome sequencing data. J Hum Genet 2021;66:637-41. [PMID: 33223521 DOI: 10.1038/s10038-020-00875-w] [Reference Citation Analysis]
48 Hall MJ, Ruth KJ, Chen DY, Gross LM, Giri VN. Interest in genomic SNP testing for prostate cancer risk: a pilot survey. Hered Cancer Clin Pract 2015;13:11. [PMID: 25874018 DOI: 10.1186/s13053-015-0032-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
49 Schupmann W, Miner SA, Sullivan HK, Glover JR, Hall JE, Schurman SH, Berkman BE. Exploring the motivations of research participants who chose not to learn medically actionable secondary genetic findings about themselves. Genet Med 2021. [PMID: 34326490 DOI: 10.1038/s41436-021-01271-1] [Reference Citation Analysis]
50 Hufnagel SB, Martin LJ, Cassedy A, Hopkin RJ, Antommaria AH. Adolescents' preferences regarding disclosure of incidental findings in genomic sequencing that are not medically actionable in childhood. Am J Med Genet A 2016;170:2083-8. [PMID: 27149544 DOI: 10.1002/ajmg.a.37730] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
51 Tabor HK, Auer PL, Jamal SM, Chong JX, Yu JH, Gordon AS, Graubert TA, O'Donnell CJ, Rich SS, Nickerson DA, Bamshad MJ; NHLBI Exome Sequencing Project. Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results. Am J Hum Genet 2014;95:183-93. [PMID: 25087612 DOI: 10.1016/j.ajhg.2014.07.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
52 Ethics Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org., Ethics Committee of the American Society for Reproductive Medicine. Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion. Fertil Steril 2018;110:625-7. [PMID: 30196948 DOI: 10.1016/j.fertnstert.2018.06.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Birkeland AC, Uhlmann WR, Brenner JC, Shuman AG. Getting personal: Head and neck cancer management in the era of genomic medicine. Head Neck 2016;38 Suppl 1:E2250-8. [PMID: 25995036 DOI: 10.1002/hed.24132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
54 Bromley E, Mendoza-Graf A, Berry S, Nebeker C, Khodyakov D. From "Informed" to "Engaged" Consent: Risks and Obligations in Consent for Participation in a Health Data Repository. J Law Med Ethics 2020;48:172-82. [PMID: 32342789 DOI: 10.1177/1073110520917007] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
55 Blackburn HL, Schroeder B, Turner C, Shriver CD, Ellsworth DL, Ellsworth RE. Management of Incidental Findings in the Era of Next-generation Sequencing. Curr Genomics 2015;16:159-74. [PMID: 26069456 DOI: 10.2174/1389202916666150317232930] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
56 Haga SB, Zhao JQ. Stakeholder views on returning research results. Adv Genet 2013;84:41-81. [PMID: 24262096 DOI: 10.1016/B978-0-12-407703-4.00002-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
57 Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015;10:93. [PMID: 26238698 DOI: 10.1186/s13023-015-0310-1] [Cited by in Crossref: 228] [Cited by in F6Publishing: 149] [Article Influence: 32.6] [Reference Citation Analysis]
58 Berkman BE, Hull SC, Eckstein L. The unintended implications of blurring the line between research and clinical care in a genomic age. Per Med 2014;11:285-95. [PMID: 25506378 DOI: 10.2217/pme.14.3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
59 Eckstein L, Garrett JR, Berkman BE. A framework for analyzing the ethics of disclosing genetic research findings. J Law Med Ethics 2014;42:190-207. [PMID: 25040383 DOI: 10.1111/jlme.12135] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
60 Hagenkord J, Funke B, Qian E, Hegde M, Jacobs KB, Ferber M, Lebo M, Buchanan A, Bick D. Design and Reporting Considerations for Genetic Screening Tests. The Journal of Molecular Diagnostics 2020;22:599-609. [DOI: 10.1016/j.jmoldx.2020.01.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
61 Raghuram Pillai P, Prows CA, Martin LJ, Myers MF. Decisional conflict among adolescents and parents making decisions about genomic sequencing results. Clin Genet 2020;97:312-20. [PMID: 31654527 DOI: 10.1111/cge.13658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Vicini P, Fields O, Lai E, Litwack ED, Martin AM, Morgan TM, Pacanowski MA, Papaluca M, Perez OD, Ringel MS. Precision medicine in the age of big data: The present and future role of large-scale unbiased sequencing in drug discovery and development. Clin Pharmacol Ther. 2016;99:198-207. [PMID: 26536838 DOI: 10.1002/cpt.293] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
63 Lázaro-Muñoz G, Conley JM, Davis AM, Prince AE, Cadigan RJ. Which Results to Return: Subjective Judgments in Selecting Medically Actionable Genes. Genet Test Mol Biomarkers 2017;21:184-94. [PMID: 28146641 DOI: 10.1089/gtmb.2016.0397] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
64 Natarajan P, Gold NB, Bick AG, McLaughlin H, Kraft P, Rehm HL, Peloso GM, Wilson JG, Correa A, Seidman JG, Seidman CE, Kathiresan S, Green RC. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans. Sci Transl Med 2016;8:364ra151. [PMID: 27831900 DOI: 10.1126/scitranslmed.aag2367] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
65 Kim SY, Karlawish J, Berkman BE. Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials. Neurology 2015;84:1488-94. [PMID: 25762713 DOI: 10.1212/WNL.0000000000001451] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
66 Thomas E, Mohammed S. Advances in Genetic Testing for Hereditary Cancer Syndromes. Recent Results Cancer Res 2016;205:1-15. [PMID: 27075345 DOI: 10.1007/978-3-319-29998-3_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Hart S, Muenke M. Genetics and genomic medicine around the world. Mol Genet Genomic Med 2014;2:1-2. [PMID: 24498624 DOI: 10.1002/mgg3.59] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
68 Gourna EG, Armstrong N, Wallace SE. Incidental findings from clinical sequencing in Greece: reporting experts' attitudes. J Community Genet 2014;5:383-93. [PMID: 25048384 DOI: 10.1007/s12687-014-0194-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
69 Christensen KD, Roberts JS, Whitehouse PJ, Royal CD, Obisesan TO, Cupples LA, Vernarelli JA, Bhatt DL, Linnenbringer E, Butson MB, Fasaye GA, Uhlmann WR, Hiraki S, Wang N, Cook-Deegan R, Green RC; REVEAL Study Group*. Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. Ann Intern Med 2016;164:155-63. [PMID: 26810768 DOI: 10.7326/M15-0187] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
70 Hamilton JG, Edwards HM, Khoury MJ, Taplin SH. Cancer screening and genetics: a tale of two paradigms. Cancer Epidemiol Biomarkers Prev 2014;23:909-16. [PMID: 24706727 DOI: 10.1158/1055-9965.EPI-13-1016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
71 Vinkšel M, Writzl K, Maver A, Peterlin B. Improving diagnostics of rare genetic diseases with NGS approaches. J Community Genet 2021;12:247-56. [PMID: 33452619 DOI: 10.1007/s12687-020-00500-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
72 Gallego CJ, Bennette CS, Heagerty P, Comstock B, Horike-Pyne M, Hisama F, Amendola LM, Bennett RL, Dorschner MO, Tarczy-Hornoch P, Grady WM, Fullerton SM, Trinidad SB, Regier DA, Nickerson DA, Burke W, Patrick DL, Jarvik GP, Veenstra DL. Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes. Contemp Clin Trials 2014;39:1-8. [PMID: 24997220 DOI: 10.1016/j.cct.2014.06.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
73 Kleiderman E, Avard D, Besso A, Ali-Khan S, Sauvageau G, Hébert J. Disclosure of incidental findings in cancer genomic research: investigators' perceptions on obligations and barriers. Clin Genet 2015;88:320-6. [PMID: 25492269 DOI: 10.1111/cge.12540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
74 Aizawa Y, Nagami F, Ohashi N, Kato K. A proposal on the first Japanese practical guidance for the return of individual genomic results in research settings. J Hum Genet 2020;65:251-61. [PMID: 31873219 DOI: 10.1038/s10038-019-0697-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
75 Wilson BJ, Nicholls SG. The Human Genome Project, and recent advances in personalized genomics. Risk Manag Healthc Policy. 2015;8:9-20. [PMID: 25733939 DOI: 10.2147/rmhp.s58728] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 5.6] [Reference Citation Analysis]
76 Pinto N, Volchenboum SL, Skol AD, Rhodes L, Doan A, Fein-Levy C, Lipton JM, Cunningham JM, Onel K. Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience. Per Med 2015;12:221-9. [PMID: 29771652 DOI: 10.2217/pme.14.90] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
77 Hao J, Hassen D, Manickam K, Murray MF, Hartzel DN, Hu Y, Liu K, Rahm AK, Williams MS, Lazzeri A, Buchanan A, Sturm A, Snyder SR. Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program. J Pers Med 2020;10:E7. [PMID: 32028596 DOI: 10.3390/jpm10010007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
78 Berkman B. Commentary on 'The right not to know and the obligation not to know'. J Med Ethics 2020;46:304-5. [PMID: 32350034 DOI: 10.1136/medethics-2020-106082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Srebniak MI, Van Opstal D, Joosten M, Diderich KE, de Vries FA, Riedijk S, Knapen MF, Go AT, Govaerts LC, Galjaard RJ. Whole-genome array as a first-line cytogenetic test in prenatal diagnosis. Ultrasound Obstet Gynecol 2015;45:363-72. [PMID: 25488734 DOI: 10.1002/uog.14745] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
80 Braverman G, Shapiro ZE, Bernstein JA. Ethical Issues in Contemporary Clinical Genetics. Mayo Clin Proc Innov Qual Outcomes 2018;2:81-90. [PMID: 30225437 DOI: 10.1016/j.mayocpiqo.2018.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
81 Turbitt E, Wiest MM, Halliday JL, Amor DJ, Metcalfe SA. Availability of treatment drives decisions of genetic health professionals about disclosure of incidental findings. Eur J Hum Genet 2014;22:1225-8. [PMID: 24496062 DOI: 10.1038/ejhg.2014.11] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
82 Angrist M, Jamal L. Living laboratory: whole-genome sequencing as a learning healthcare enterprise. Clin Genet 2015;87:311-8. [PMID: 25045831 DOI: 10.1111/cge.12461] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
83 Bodian DL, McCutcheon JN, Kothiyal P, Huddleston KC, Iyer RK, Vockley JG, Niederhuber JE. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing. PLoS One. 2014;9:e94554. [PMID: 24728327 DOI: 10.1371/journal.pone.0094554] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
84 Werner-lin A, Tomlinson A, Miller V, Bernhardt BA. Adolescent engagement during assent for exome sequencing. AJOB Empirical Bioethics 2016;7:275-84. [DOI: 10.1080/23294515.2016.1197983] [Cited by in Crossref: 8] [Article Influence: 1.3] [Reference Citation Analysis]
85 Winkler EC, Wiemann S. Findings made in gene panel to whole genome sequencing: data, knowledge, ethics – and consequences? Expert Review of Molecular Diagnostics 2016;16:1259-70. [DOI: 10.1080/14737159.2016.1212662] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
86 Morello-Frosch R, Varshavsky J, Liboiron M, Brown P, Brody JG. Communicating results in post-Belmont era biomonitoring studies: lessons from genetics and neuroimaging research. Environ Res 2015;136:363-72. [PMID: 25460657 DOI: 10.1016/j.envres.2014.10.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
87 Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, Biswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM, Everett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston JJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J, Plon SE, Rehm HL, Richards CS, Romasko EJ, Miren Sagardia A, Spinner NB, Thompson ML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker LG, Hindorff LA. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med 2019;21:1100-10. [PMID: 30287922 DOI: 10.1038/s41436-018-0308-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 13.5] [Reference Citation Analysis]
88 Shaibi GQ, Kullo IJ, Singh DP, Sharp RR, De Filippis E, Cuellar I, Hernandez V, Levey S, Radecki Breitkopf C, Olson JE, Cerhan JR, Mandarino LJ, Thibodeau SN, Lindor NM. Developing a Process for Returning Medically Actionable Genomic Variants to Latino Patients in a Federally Qualified Health Center. Public Health Genomics 2018;21:77-84. [PMID: 30522109 DOI: 10.1159/000494488] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
89 Pezeshkpoor B, Oldenburg J, Pavlova A. Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders. Hamostaseologie 2022. [PMID: 35226963 DOI: 10.1055/a-1726-4793] [Reference Citation Analysis]
90 Nestor JG, Groopman EE, Gharavi AG. Towards precision nephrology: the opportunities and challenges of genomic medicine. J Nephrol 2018;31:47-60. [PMID: 29043570 DOI: 10.1007/s40620-017-0448-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
91 Lenardo M, Lo B, Lucas CL. Genomics of Immune Diseases and New Therapies. Annu Rev Immunol 2016;34:121-49. [PMID: 26735698 DOI: 10.1146/annurev-immunol-041015-055620] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
92 Roberts JS, Dolinoy D, Tarini B. Emerging issues in public health genomics. Annu Rev Genomics Hum Genet 2014;15:461-80. [PMID: 25184533 DOI: 10.1146/annurev-genom-090413-025514] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
93 Dal-Ré R, Katsanis N, Katsanis S, Parker LS, Ayuso C. Managing incidental genomic findings in clinical trials: fulfillment of the principle of justice. PLoS Med 2014;11:e1001584. [PMID: 24453945 DOI: 10.1371/journal.pmed.1001584] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
94 Carethers JM. DNA testing and molecular screening for colon cancer. Clin Gastroenterol Hepatol. 2014;12:377-381. [PMID: 24355100 DOI: 10.1016/j.cgh.2013.12.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
95 Warren-Gash C, Kroese M, Burton H, Pharoah P. Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study. Hered Cancer Clin Pract 2016;14:12. [PMID: 27252788 DOI: 10.1186/s13053-016-0052-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Boycott K, Hartley T, Adam S, Bernier F, Chong K, Fernandez BA, Friedman JM, Geraghty MT, Hume S, Knoppers BM, Laberge AM, Majewski J, Mendoza-Londono R, Meyn MS, Michaud JL, Nelson TN, Richer J, Sadikovic B, Skidmore DL, Stockley T, Taylor S, van Karnebeek C, Zawati MH, Lauzon J, Armour CM; Canadian College of Medical Geneticists. The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists. J Med Genet 2015;52:431-7. [PMID: 25951830 DOI: 10.1136/jmedgenet-2015-103144] [Cited by in Crossref: 120] [Cited by in F6Publishing: 113] [Article Influence: 17.1] [Reference Citation Analysis]
97 Wynn J, Lewis K, Amendola LM, Bernhardt BA, Biswas S, Joshi M, McMullen C, Scollon S. Clinical providers' experiences with returning results from genomic sequencing: an interview study. BMC Med Genomics 2018;11:45. [PMID: 29739461 DOI: 10.1186/s12920-018-0360-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
98 Etchegary H, Pullman D, Simmonds C, Rahman P. Public interest in unexpected genomic findings: a survey study identifying aspects of sequencing attitudes that influence preferences. J Community Genet. [DOI: 10.1007/s12687-022-00577-0] [Reference Citation Analysis]
99 Ormond KE, O'daniel JM, Kalia SS. Secondary findings: How did we get here, and where are we going? J Genet Couns 2019;28:326-33. [DOI: 10.1002/jgc4.1098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
100 Bashamboo A, McElreavey K. The role of next generation sequencing in understanding male and female sexual development: clinical implications. Expert Rev Endocrinol Metab 2016;11:433-43. [PMID: 30058910 DOI: 10.1080/17446651.2016.1220299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
101 Brothers KB, Rothstein MA. Ethical, legal and social implications of incorporating personalized medicine into healthcare. Per Med 2015;12:43-51. [PMID: 25601880 DOI: 10.2217/pme.14.65] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
102 Wan Z, Hazel JW, Clayton EW, Vorobeychik Y, Kantarcioglu M, Malin BA. Sociotechnical safeguards for genomic data privacy. Nat Rev Genet 2022. [PMID: 35246669 DOI: 10.1038/s41576-022-00455-y] [Reference Citation Analysis]
103 Waltz M, Cadigan RJ, Prince AER, Skinner D, Henderson GE. Age and perceived risks and benefits of preventive genomic screening. Genet Med 2018;20:1038-44. [PMID: 29215654 DOI: 10.1038/gim.2017.206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
104 Pinxten W, Howard HC. Ethical issues raised by whole genome sequencing. Best Practice & Research Clinical Gastroenterology 2014;28:269-79. [DOI: 10.1016/j.bpg.2014.02.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
105 Yu JH, Harrell TM, Jamal SM, Tabor HK, Bamshad MJ. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing. Am J Hum Genet 2014;95:77-84. [PMID: 24975944 DOI: 10.1016/j.ajhg.2014.06.004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 11.1] [Reference Citation Analysis]
106 Prows CA, Tran G, Blosser B. Whole exome or genome sequencing: nurses need to prepare families for the possibilities. J Adv Nurs 2014;70:2736-45. [DOI: 10.1111/jan.12516] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
107 Janssens AC, Patch C, Skirton H. Predictive or not predictive: understanding the mixed messages from the patient's DNA sequence. J Clin Nurs 2015;24:3730-5. [PMID: 26542756 DOI: 10.1111/jocn.13079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
108 Stowell KM. DNA testing for malignant hyperthermia: the reality and the dream. Anesth Analg 2014;118:397-406. [PMID: 24445638 DOI: 10.1213/ANE.0000000000000063] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
109 Mann SP, Treit PV, Geyer PE, Omenn GS, Mann M. Ethical Principles, Constraints and Opportunities in Clinical Proteomics. Mol Cell Proteomics 2021;:100046. [PMID: 33453411 DOI: 10.1016/j.mcpro.2021.100046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
110 Ward ET, Kostick KM, Lázaro-Muñoz G. Integrating Genomics into Psychiatric Practice: Ethical and Legal Challenges for Clinicians. Harv Rev Psychiatry 2019;27:53-64. [PMID: 30614887 DOI: 10.1097/HRP.0000000000000203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
111 Rothstein MA. Reconsidering the duty to warn genetically at-risk relatives. Genet Med 2018;20:285-90. [PMID: 29388945 DOI: 10.1038/gim.2017.257] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
112 Lázaro-Muñoz G, Conley JM, Davis AM, Van Riper M, Walker RL, Juengst ET. Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice. Am J Bioeth 2015;15:3-14. [PMID: 26147254 DOI: 10.1080/15265161.2015.1039721] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
113 Barajas M, Ross LF. Pediatric Professionals' Attitudes about Secondary Findings in Genomic Sequencing of Children. The Journal of Pediatrics 2015;166:1276-1282.e7. [DOI: 10.1016/j.jpeds.2015.01.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
114 Freed AS, Gruß I, McMullen CK, Leo MC, Kauffman TL, Porter KM, Muessig KR, Eubanks D, Goddard KAB, Wilfond BS, Liles EG. A decision aid for additional findings in genomic sequencing: Development and pilot testing. Patient Educ Couns 2021;104:960-8. [PMID: 33191058 DOI: 10.1016/j.pec.2020.10.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
115 Pinard A, Miltgen M, Blanchard A, Mathieu H, Desvignes JP, Salgado D, Fabre A, Arnaud P, Barré L, Krahn M, Grandval P, Olschwang S, Zaffran S, Boileau C, Béroud C, Collod-Béroud G. Actionable Genes, Core Databases, and Locus-Specific Databases. Hum Mutat 2016;37:1299-307. [PMID: 27600092 DOI: 10.1002/humu.23112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
116 Hamilton JG, Shuk E, Genoff MC, Rodríguez VM, Hay JL, Offit K, Robson ME. Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling. J Oncol Pract 2017;13:e590-601. [PMID: 28628391 DOI: 10.1200/JOP.2016.020057] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
117 Adam S, Friedman JM. Individual DNA samples and health information sold by 23andMe. Genet Med 2016;18:305-6. [DOI: 10.1038/gim.2015.82] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
118 Tolusso LK, Collins K, Zhang X, Holle JR, Valencia CA, Myers MF. Pediatric Whole Exome Sequencing: an Assessment of Parents’ Perceived and Actual Understanding. J Genet Counsel 2017;26:792-805. [DOI: 10.1007/s10897-016-0052-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
119 Joshi E, Mighton C, Clausen M, Casalino S, Kim THM, Kowal C, Birken C, Maguire JL, Bombard Y. Primary care provider perspectives on using genomic sequencing in the care of healthy children. Eur J Hum Genet 2020;28:551-7. [PMID: 31804631 DOI: 10.1038/s41431-019-0547-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Poduri A, Sheidley BR, Shostak S, Ottman R. Genetic testing in the epilepsies-developments and dilemmas. Nat Rev Neurol 2014;10:293-9. [PMID: 24733164 DOI: 10.1038/nrneurol.2014.60] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
121 Gebresilase TT, Deresse Z, Tsegay G, Tessema TS, Aseffa A, Davey G, Newport M, Tekola-ayele F, Addissie A. Rapid Ethical Appraisal: A tool to design a contextualized consent process for a genetic study of podoconiosis in Ethiopia. Wellcome Open Res 2017;2:99. [DOI: 10.12688/wellcomeopenres.12613.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
122 McInerney-Leo AM, Duncan EL. Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls. Front Endocrinol (Lausanne) 2020;11:628946. [PMID: 33679611 DOI: 10.3389/fendo.2020.628946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Lewis ACF, Green RC. Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues. Genome Med 2021;13:14. [PMID: 33509269 DOI: 10.1186/s13073-021-00829-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
124 Richer J, Laberge A. Secondary findings from next-generation sequencing: what does actionable in childhood really mean? Genet Med 2019;21:124-32. [DOI: 10.1038/s41436-018-0034-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
125 Dasgupta S. Medical Genetics Ethics Case Collection: Discussion Materials for Medical Students in the Genomic Era. MedEdPORTAL 2017;13:10562. [PMID: 30800764 DOI: 10.15766/mep_2374-8265.10562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
126 Williams JK, Cashion AK, Veenstra DL. Challenges in evaluating next-generation sequence data for clinical decisions. Nurs Outlook 2015;63:48-50. [PMID: 25261386 DOI: 10.1016/j.outlook.2014.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
127 Horiuchi Y, Matsubayashi H, Kiyozumi Y, Nishimura S, Higashigawa S, Kado N, Nagashima T, Mizuguchi M, Ohnami S, Arai M, Urakami K, Kusuhara M, Yamaguchi K. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients. Hum Genet 2021;140:321-31. [PMID: 32710294 DOI: 10.1007/s00439-020-02207-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Hayeems RZ, Dimmock D, Bick D, Belmont JW, Green RC, Lanpher B, Jobanputra V, Mendoza R, Kulkarni S, Grove ME, Taylor SL, Ashley E; Medical Genome Initiative. Clinical utility of genomic sequencing: a measurement toolkit. NPJ Genom Med 2020;5:56. [PMID: 33319814 DOI: 10.1038/s41525-020-00164-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
129 Lemke AA, Harris-Wai JN. Stakeholder engagement in policy development: challenges and opportunities for human genomics. Genet Med 2015;17:949-57. [PMID: 25764215 DOI: 10.1038/gim.2015.8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]
130 Mackley MP, Capps B. Expect the unexpected: screening for secondary findings in clinical genomics research. Br Med Bull 2017;122:109-22. [PMID: 28398474 DOI: 10.1093/bmb/ldx009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
131 Hull SC, Berkman BE. Grappling with genomic incidental findings in the clinical realm. Chest 2014;145:226-30. [PMID: 24493507 DOI: 10.1378/chest.13-1976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
132 Christensen KD, Roberts JS, Zikmund-Fisher BJ, Kardia SL, McBride CM, Linnenbringer E, Green RC; REVEAL Study Group. Associations between self-referral and health behavior responses to genetic risk information. Genome Med 2015;7:10. [PMID: 25642295 DOI: 10.1186/s13073-014-0124-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
133 Juengst E, McGowan ML, Fishman JR, Settersten RA Jr. From "Personalized" to "Precision" Medicine: The Ethical and Social Implications of Rhetorical Reform in Genomic Medicine. Hastings Cent Rep 2016;46:21-33. [PMID: 27649826 DOI: 10.1002/hast.614] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 15.3] [Reference Citation Analysis]
134 Fossey R, Kochan D, Winkler E, Pacyna JE, Olson J, Thibodeau S, Connolly JJ, Harr M, Behr MA, Prows CA, Cobb B, Myers MF, Leslie ND, Namjou-Khales B, Milo Rasouly H, Wynn J, Fedotov A, Chung WK, Gharavi A, Williams JL, Pais L, Holm I, Aufox S, Smith ME, Scrol A, Leppig K, Jarvik GP, Wiesner GL, Li R, Stroud M, Smoller JW, Sharp RR, Kullo IJ. Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience. J Pers Med 2018;8:E2. [PMID: 29301385 DOI: 10.3390/jpm8010002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
135 Zawati MH, Parry D, Thorogood A, Nguyen MT, Boycott KM, Rosenblatt D, Knoppers BM. Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada? J Med Genet 2013;51:68-70. [DOI: 10.1136/jmedgenet-2013-101934] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
136 Grubs RE, Parker LS, Hamilton R. Subtle Psychosocial Sequelae of Genetic Test Results. Curr Genet Med Rep 2014;2:242-9. [DOI: 10.1007/s40142-014-0053-7] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
137 Wouters RHP, Bijlsma RM, Frederix GWJ, Ausems MGEM, van Delden JJM, Voest EE, Bredenoord AL. Is It Our Duty To Hunt for Pathogenic Mutations? Trends Mol Med 2018;24:3-6. [PMID: 29246758 DOI: 10.1016/j.molmed.2017.11.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
138 Jamuar SS, Kuan JL, Brett M, Tiang Z, Tan WL, Lim JY, Liew WK, Javed A, Liew WK, Law HY, Tan ES, Lai A, Ng I, Teo YY, Venkatesh B, Reversade B, Tan EC, Foo R. Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine? EBioMedicine 2016;5:211-6. [PMID: 27077130 DOI: 10.1016/j.ebiom.2016.01.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
139 Ryan KA, De Vries RG, Uhlmann WR, Roberts JS, Gornick MC. Public's Views toward Return of Secondary Results in Genomic Sequencing: It's (Almost) All about the Choice. J Genet Couns 2017;26:1197-212. [PMID: 28357777 DOI: 10.1007/s10897-017-0095-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
140 Grond-Ginsbach C, Erhart P, Chen B, Kloss M, Engelter ST, Cole JW. Copy Number Variation and Risk of Stroke. Stroke 2018;49:2549-54. [PMID: 30355123 DOI: 10.1161/STROKEAHA.118.020371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Skinner D, Raspberry KA, King M. The nuanced negative: Meanings of a negative diagnostic result in clinical exome sequencing. Sociol Health Illn 2016;38:1303-17. [PMID: 27538589 DOI: 10.1111/1467-9566.12460] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
142 Garrison NA. Considerations for Returning Research Results to Culturally Diverse Participants and Families of Decedents. J Law Med Ethics 2015;43:569-75. [PMID: 26479567 DOI: 10.1111/jlme.12300] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
143 Krier JB, Green RC. Management of Incidental Findings in Clinical Genomic Sequencing. Curr Protoc Hum Genet 2015;87:9.23.1-9.23.16. [PMID: 26439717 DOI: 10.1002/0471142905.hg0923s87] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
144 Vu M, Degeling K, Martyn M, Lynch E, Chong B, Gaff C, IJzerman MJ. Evaluating the resource implications of different service delivery models for offering additional genomic findings. Genet Med 2021;23:606-13. [PMID: 33214711 DOI: 10.1038/s41436-020-01030-8] [Reference Citation Analysis]
145 Danielsson K, Mun LJ, Lordemann A, Mao J, Lin CH. Next-generation sequencing applied to rare diseases genomics. Expert Rev Mol Diagn. 2014;14:469-487. [PMID: 24702023 DOI: 10.1586/14737159.2014.904749] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
146 Glade Bender J, Verma A, Schiffman JD. Translating genomic discoveries to the clinic in pediatric oncology. Current Opinion in Pediatrics 2015;27:34-43. [DOI: 10.1097/mop.0000000000000172] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
147 Wolf SM. The Continuing Evolution of Ethical Standards for Genomic Sequencing in Clinical Care: Restoring Patient Choice. J Law Med Ethics 2017;45:333-40. [PMID: 30100701 DOI: 10.1177/1073110517737531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
148 Allyse M, Evans JP, Michie M. Dr. Pangloss's Clinic: Prenatal Whole Genome Sequencing and a Return to Reality. Am J Bioeth 2017;17:21-3. [PMID: 27996895 DOI: 10.1080/15265161.2016.1251660] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
149 Holm IA, McGuire A, Pereira S, Rehm H, Green RC, Beggs AH; BabySeq Project Team. Returning a Genomic Result for an Adult-Onset Condition to the Parents of a Newborn: Insights From the BabySeq Project. Pediatrics 2019;143:S37-43. [PMID: 30600270 DOI: 10.1542/peds.2018-1099H] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
150 Frieser MJ, Wilson S, Vrieze S. Behavioral impact of return of genetic test results for complex disease: Systematic review and meta-analysis. Health Psychol 2018;37:1134-44. [PMID: 30307272 DOI: 10.1037/hea0000683] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
151 Khan CM, Rini C, Bernhardt BA, Roberts JS, Christensen KD, Evans JP, Brothers KB, Roche MI, Berg JS, Henderson GE. How can psychological science inform research about genetic counseling for clinical genomic sequencing? J Genet Couns 2015;24:193-204. [PMID: 25488723 DOI: 10.1007/s10897-014-9804-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
152 Bick D, Fraser PC, Gutzeit MF, Harris JM, Hambuch TM, Helbling DC, Jacob HJ, Kersten JN, Leuthner SR, May T, North PE, Prisco SZ, Schuler BA, Shimoyama M, Strong KA, Van Why SK, Veith R, Verbsky J, Weborg AM Jr, Wilk BM, Willoughby RE Jr, Worthey EA, Dimmock DP. Successful Application of Whole Genome Sequencing in a Medical Genetics Clinic. J Pediatr Genet 2017;6:61-76. [PMID: 28496993 DOI: 10.1055/s-0036-1593968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 27] [Article Influence: 0.5] [Reference Citation Analysis]
153 Hoang N, Cytrynbaum C, Scherer SW. Communicating complex genomic information: A counselling approach derived from research experience with Autism Spectrum Disorder. Patient Educ Couns 2018;101:352-61. [PMID: 28803755 DOI: 10.1016/j.pec.2017.07.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
154 Bowdin S, Ray PN, Cohn RD, Meyn MS. The Genome Clinic: A Multidisciplinary Approach to Assessing the Opportunities and Challenges of Integrating Genomic Analysis into Clinical Care. Human Mutation 2014;35:513-9. [DOI: 10.1002/humu.22536] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
155 Mighton C, Carlsson L, Clausen M, Casalino S, Shickh S, McCuaig L, Joshi E, Panchal S, Graham T, Aronson M, Piccinin C, Winter-Paquette L, Semotiuk K, Lorentz J, Mancuso T, Ott K, Silberman Y, Elser C, Eisen A, Kim RH, Lerner-Ellis J, Carroll JC, Glogowski E, Schrader K, Bombard Y; Incidental Genomics Study Team. Development of patient "profiles" to tailor counseling for incidental genomic sequencing results. Eur J Hum Genet 2019;27:1008-17. [PMID: 30846854 DOI: 10.1038/s41431-019-0352-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
156 Meiser B, Storey B, Quinn V, Rahman B, Andrews L. Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study. J Genet Couns 2016;25:218-27. [PMID: 26259529 DOI: 10.1007/s10897-015-9861-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
157 Wong CS, Kogon AJ, Warady BA, Furth SL, Lantos JD, Wilfond BS. Ethical and Policy Considerations for Genomic Testing in Pediatric Research: The Path Toward Disclosing Individual Research Results. Am J Kidney Dis 2019;73:837-45. [PMID: 30879919 DOI: 10.1053/j.ajkd.2019.01.020] [Reference Citation Analysis]
158 Berg JS, Powell CM. Potential Uses and Inherent Challenges of Using Genome-Scale Sequencing to Augment Current Newborn Screening. Cold Spring Harb Perspect Med 2015;5:a023150. [PMID: 26438605 DOI: 10.1101/cshperspect.a023150] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
159 Fadda M, Fiordelli M, Amati R, Falvo I, Ibnidris A, Hurst S, Albanese E. Returning individual-specific results of a dementia prevalence study: insights from prospective participants living in Switzerland. Int J Geriatr Psychiatry 2021;36:207-14. [PMID: 32869397 DOI: 10.1002/gps.5416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
160 Parsons DW, Roy A, Plon SE, Roychowdhury S, Chinnaiyan AM. Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings. J Clin Oncol 2014;32:2203-5. [PMID: 24958819 DOI: 10.1200/JCO.2013.54.8917] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
161 Saelaert M, Mertes H, De Baere E, Devisch I. Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate. Eur J Hum Genet 2018;26:1424-31. [PMID: 29970927 DOI: 10.1038/s41431-018-0200-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
162 Milner LC, Garrison NA, Cho MK, Altman RB, Hudgins L, Galli SJ, Lowe HJ, Schrijver I, Magnus DC. Genomics in the clinic: ethical and policy challenges in clinical next-generation sequencing programs at early adopter USA institutions. Per Med 2015;12:269-82. [PMID: 29771644 DOI: 10.2217/pme.14.88] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
163 Adam S, Friedman JM. Controversy and debate on clinical genomics sequencing-paper 2: clinical genome-wide sequencing: don't throw out the baby with the bathwater! J Clin Epidemiol 2017;92:7-10. [PMID: 28916491 DOI: 10.1016/j.jclinepi.2017.08.020] [Reference Citation Analysis]
164 Grosse SD, Gurrin LC, Bertalli NA, Allen KJ. Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes. Genet Med 2018;20:383-9. [PMID: 28771247 DOI: 10.1038/gim.2017.121] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
165 Gourna EG, Armstrong N, Wallace SE. Compare and contrast: a cross-national study across UK, USA and Greek experts regarding return of incidental findings from clinical sequencing. Eur J Hum Genet 2016;24:344-9. [PMID: 26059844 DOI: 10.1038/ejhg.2015.132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
166 Raje N, Soden S, Swanson D, Ciaccio CE, Kingsmore SF, Dinwiddie DL. Utility of next generation sequencing in clinical primary immunodeficiencies. Curr Allergy Asthma Rep 2014;14:468. [PMID: 25149170 DOI: 10.1007/s11882-014-0468-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
167 Schuol S, Schickhardt C, Wiemann S, Bartram CR, Tanner K, Eils R, Meder B, Richter D, Glimm H, von Kalle C, Winkler EC. So rare we need to hunt for them: reframing the ethical debate on incidental findings. Genome Med 2015;7:83. [PMID: 26229554 DOI: 10.1186/s13073-015-0198-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
168 Berkman BE, Hull SC. The "right not to know" in the genomic era: time to break from tradition? Am J Bioeth 2014;14:28-31. [PMID: 24592837 DOI: 10.1080/15265161.2014.880313] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
169 Hamilton JG, Shuk E, Garzon MG, Rodríguez VM, Westerman J, Hay JL, Offit K, Robson ME. Decision-Making Preferences About Secondary Germline Findings That Arise From Tumor Genomic Profiling Among Patients With Advanced Cancers. JCO Precis Oncol 2017;1. [PMID: 31938761 DOI: 10.1200/PO.17.00182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
170 Berg JS, Foreman AK, O'Daniel JM, Booker JK, Boshe L, Carey T, Crooks KR, Jensen BC, Juengst ET, Lee K, Nelson DK, Powell BC, Powell CM, Roche MI, Skrzynia C, Strande NT, Weck KE, Wilhelmsen KC, Evans JP. A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing. Genet Med 2016;18:467-75. [PMID: 26270767 DOI: 10.1038/gim.2015.104] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
171 Holm IA. Clinical Management of Pediatric Genomic Testing. Curr Genet Med Rep 2014;2:212-5. [PMID: 25396100 DOI: 10.1007/s40142-014-0052-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
172 Oetjens MT, Bush WS, Denny JC, Birdwell K, Kodaman N, Verma A, Dilks HH, Pendergrass SA, Ritchie MD, Crawford DC. Evidence for extensive pleiotropy among pharmacogenes. Pharmacogenomics 2016;17:853-66. [PMID: 27249515 DOI: 10.2217/pgs-2015-0007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
173 Bowdin SC, Hayeems RZ, Monfared N, Cohn RD, Meyn MS. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine. Clin Genet 2016;89:10-9. [PMID: 25813238 DOI: 10.1111/cge.12579] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
174 Graves KD, Hay JL, O'Neill SC. The promise of using personalized genomic information to promote behavior change: is the debate over, or just beginning? Per Med 2014;11:173-85. [PMID: 29751381 DOI: 10.2217/pme.13.110] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
175 O'Neill SC, Tercyak KP, Baytop C, Hensley Alford S, McBride CM. A new approach to assessing affect and the emotional implications of personal genomic testing for common disease risk. Public Health Genomics 2015;18:104-12. [PMID: 25612474 DOI: 10.1159/000370101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
176 Kleiderman E, Knoppers BM, Fernandez CV, Boycott KM, Ouellette G, Wong-Rieger D, Adam S, Richer J, Avard D. Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases. J Med Ethics 2014;40:691-6. [PMID: 24356209 DOI: 10.1136/medethics-2013-101648] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
177 Benedetti DJ, Marron JM. Ethical Challenges in Pediatric Oncology Care and Clinical Trials. Recent Results Cancer Res 2021;218:149-73. [PMID: 34019168 DOI: 10.1007/978-3-030-63749-1_11] [Reference Citation Analysis]
178 Strong KA, Zusevics KL, Bick D, Veith R. Views of primary care providers regarding the return of genome sequencing incidental findings. Clin Genet 2014;86:461-8. [PMID: 24673592 DOI: 10.1111/cge.12390] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
179 Jelsig AM, Qvist N, Brusgaard K, Ousager LB. Research participants in NGS studies want to know about incidental findings. Eur J Hum Genet 2015;23:1423-6. [PMID: 25604854 DOI: 10.1038/ejhg.2014.298] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
180 Harrington JW, Emuren L, Restaino K, Schrier Vergano S. Parental Perception and Participation in Genetic Testing Among Children With Autism Spectrum Disorders. Clin Pediatr (Phila) 2018;57:1642-55. [DOI: 10.1177/0009922818803398] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
181 Evans BJ, Javitt G, Hall R, Robertson M, Ossorio P, Wolf SM, Morgan T, Clayton EW; LawSeq Quality Task Force. How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care? J Law Med Ethics 2020;48:44-68. [PMID: 32342785 DOI: 10.1177/1073110520916995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
182 Sénécal K, Rahimzadeh V, Knoppers BM, Fernandez CV, Avard D, Sinnett D. Statement of principles on the return of research results and incidental findings in paediatric research: a multi-site consultative process. Genome 2015;58:541-8. [PMID: 26613133 DOI: 10.1139/gen-2015-0092] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
183 Isasi R. Stem Cell Research and Banking: Towards Policy on Disclosing Research Results and Incidental Findings. In: Ilic D, editor. Stem Cell Banking. New York: Springer; 2014. pp. 29-40. [DOI: 10.1007/978-1-4939-0585-0_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 Owens K. The passivists: Managing risk through institutionalized ignorance in genomic medicine. Soc Sci Med 2022;294:114715. [PMID: 35033797 DOI: 10.1016/j.socscimed.2022.114715] [Reference Citation Analysis]
185 Wolf SM, Burke W, Koenig BA. Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide. J Law Med Ethics 2015;43:486-501. [PMID: 26479558 DOI: 10.1111/jlme.12291] [Cited by in Crossref: 16] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
186 Lázaro-Muñoz G. The fiduciary relationship model for managing clinical genomic "incidental" findings. J Law Med Ethics 2014;42:576-89. [PMID: 25565622 DOI: 10.1111/jlme.12177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
187 Smith LA, Douglas J, Braxton AA, Kramer K. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling. J Genet Couns 2015;24:654-62. [PMID: 25403901 DOI: 10.1007/s10897-014-9794-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
188 Lohmann K, Klein C. Next generation sequencing and the future of genetic diagnosis. Neurotherapeutics 2014;11:699-707. [PMID: 25052068 DOI: 10.1007/s13311-014-0288-8] [Cited by in Crossref: 89] [Cited by in F6Publishing: 71] [Article Influence: 12.7] [Reference Citation Analysis]
189 Johnson LM, Hamilton KV, Valdez JM, Knapp E, Baker JN, Nichols KE. Ethical considerations surrounding germline next-generation sequencing of children with cancer. Expert Rev Mol Diagn 2017;17:523-34. [PMID: 28399664 DOI: 10.1080/14737159.2017.1316665] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
190 Fernandez CV, O'Rourke PP, Beskow LM. Canadian Research Ethics Board Leadership Attitudes to the Return of Genetic Research Results to Individuals and Their Families. J Law Med Ethics 2015;43:514-22. [PMID: 26479560 DOI: 10.1111/jlme.12293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
191 Phillips KA, Trosman JR, Kelley RK, Pletcher MJ, Douglas MP, Weldon CB. Genomic sequencing: assessing the health care system, policy, and big-data implications. Health Aff (Millwood) 2014;33:1246-53. [PMID: 25006153 DOI: 10.1377/hlthaff.2014.0020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
192 Coors ME, Raymond KM, McWilliams SK, Hopfer CJ, Mikulich-Gilbertson SK. Adolescent perspectives on the return of individual results in genomic addiction research. Psychiatr Genet 2015;25:127-30. [PMID: 25748091 DOI: 10.1097/YPG.0000000000000083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
193 Wilfond BS, Fernandez CV, Green RC. Disclosing Secondary Findings from Pediatric Sequencing to Families: Considering the "Benefit to Families". J Law Med Ethics 2015;43:552-8. [PMID: 26479565 DOI: 10.1111/jlme.12298] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
194 Linderman MD, Nielsen DE, Green RC. Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium. J Pers Med 2016;6:E14. [PMID: 27023617 DOI: 10.3390/jpm6020014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
195 Rotz SJ, Kodish E. Ethical conundrums in pediatric genomics. Hematology Am Soc Hematol Educ Program 2018;2018:301-6. [PMID: 30504324 DOI: 10.1182/asheducation-2018.1.301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
196 Fisher E, Achilles S, Tönnies H, Schmidtke J. [Concepts for the return of secondary genetic findings in medical diagnostics and research]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015;58:166-73. [PMID: 25487853 DOI: 10.1007/s00103-014-2096-z] [Reference Citation Analysis]
197 Piciocchi C, Ducato R, Martinelli L, Perra S, Tomasi M, Zuddas C, Mascalzoni D. Legal issues in governing genetic biobanks: the Italian framework as a case study for the implications for citizen's health through public-private initiatives. J Community Genet 2018;9:177-90. [PMID: 28921376 DOI: 10.1007/s12687-017-0328-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 Anderson JA, Hayeems RZ, Shuman C, Szego MJ, Monfared N, Bowdin S, Zlotnik Shaul R, Meyn MS. Predictive genetic testing for adult-onset disorders in minors: a critical analysis of the arguments for and against the 2013 ACMG guidelines. Clin Genet 2015;87:301-10. [PMID: 25046648 DOI: 10.1111/cge.12460] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
199 Yu JH, Crouch J, Jamal SM, Bamshad MJ, Tabor HK. Attitudes of non-African American focus group participants toward return of results from exome and whole genome sequencing. Am J Med Genet A 2014;164A:2153-60. [PMID: 24845082 DOI: 10.1002/ajmg.a.36610] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
200 Marron JM, Joffe S. Ethical considerations in genomic testing for hematologic disorders. Blood 2017;130:460-5. [PMID: 28600340 DOI: 10.1182/blood-2017-01-734558] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
201 Knoppers BM, Avard D, Sénécal K, Zawati MH; P3G International Paediatrics Platform Members. Return of whole-genome sequencing results in paediatric research: a statement of the P3G international paediatrics platform. Eur J Hum Genet 2014;22:3-5. [PMID: 23921532 DOI: 10.1038/ejhg.2013.176] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.2] [Reference Citation Analysis]
202 Saelaert M, Mertes H, Moerenhout T, De Baere E, Devisch I. Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study. BMC Med Ethics 2020;21:9. [PMID: 32000764 DOI: 10.1186/s12910-020-0452-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
203 Mackley MP, Fletcher B, Parker M, Watkins H, Ormondroyd E. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies. Genet Med 2017;19:283-93. [PMID: 27584911 DOI: 10.1038/gim.2016.109] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 12.3] [Reference Citation Analysis]
204 Lawrence L, Sincan M, Markello T, Adams DR, Gill F, Godfrey R, Golas G, Groden C, Landis D, Nehrebecky M, Park G, Soldatos A, Tifft C, Toro C, Wahl C, Wolfe L, Gahl WA, Boerkoel CF. The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience. Genet Med 2014;16:741-50. [PMID: 24784157 DOI: 10.1038/gim.2014.29] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
205 Pinheiro APM, Pocock RH, Switchenko JM, Dixon MD, Shaib WL, Ramalingam SS, Pentz RD. Discussing molecular testing in oncology care: Comparing patient and physician information preferences. Cancer 2017;123:1610-6. [PMID: 28140456 DOI: 10.1002/cncr.30494] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]